Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 3090 (LINC03090) is a non-protein coding RNA gene classified as a long intergenic non-coding RNA (lincRNA)[1][3][7]. LincRNAs are autonomously transcribed non-coding RNAs longer than 200 nucleotides that do not overlap annotated protein-coding genes, and they are known to play diverse roles such as remodeling chromatin, fine-tuning gene expression, regulating transcription, and stabilizing RNA. Many lincRNAs act via sequence-independent mechanisms, often functioning as regulators of neighboring genes or through enhancer-like activities. The specific biological functions, disease associations, or therapeutic targeting potential of LINC03090 itself remain poorly characterized, and it is not currently considered a direct therapeutic target[1][3][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 3090 (LINC03090).